Quick Overview: Yale Cancer Center Grand Rounds May 21, 2019 Roy Decker, MD, PhD, Vice Chair for Clinical Research and Professor of ... In this episode, Sandip Patel, MD shares his thoughts on Natalie Vokes, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, comments on the challenges of choosing ...
Optimizing Checkpoint Inhibition In Nsclc - Detailed Overview & Context
Yale Cancer Center Grand Rounds May 21, 2019 Roy Decker, MD, PhD, Vice Chair for Clinical Research and Professor of ... In this episode, Sandip Patel, MD shares his thoughts on Natalie Vokes, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, comments on the challenges of choosing ... In this section, Drs Weiner, Socinski, and Herbst discuss immune Heather Wakelee, MD, discusses the mechanism of action and rationale for using Luis Raez, MD, FACP, FCCP, Memorial Healthcare System, Pembroke Pines, FL, describes treatment strategies for patients with ...
Dr. Jack West summarizes the rationale for testing immune Biagio Ricciuti, MD, Dana-Farber Cancer Institute, Boston, MA, comments on the current role of neoadjuvant immunotherapy in ... Benjamin P. Levy, MD; Naiyer A. Rizvi, MD; Suresh S. Ramalingam, MD; Roy S. Herbst, MD, PhD; and Hossein Borghaei, DO, MS, ... This video is part of a larger CE/CME Certified program entitled: Navigating First-Line Benjamin P. Levy, MD; Suresh S. Ramalingam, MD; Roy S. Herbst, MD, PhD; and Naiyer A. Rizvi, MD, describe the ongoing trials ... Panelists Mark A. Socinski, MD; Thomas E. Stinchcombe, MD; Benjamin P. Levy, MD; and Gregory J. Riely, MD, PhD; highlight the ...
Bruna Pellini, MD, Moffitt Cancer Center, Tampa, FL, discusses the past, present and future of Benjamin P. Levy, MD; Roy S. Herbst, MD, PhD; Hossain Borghaei, DO, MS; Naiyer A. Rizvi, MD; Suresh S. Ramalingam, MD; and ... Marina Garassino, MD, of National Cancer Institute of Milan, Milan, Italy, discusses the combined use of chemotherapy and ... The Oncodistinct network & Institut Jules Bordet Luis Castelo-Branco MD & Gil Morgan MD. In this segment, experts discuss sequencing immune
